✦ LIBER ✦

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

✍ Scribed by Itamar Raz; Ulrik Mouritzen; Julius Vaz; Tommy Hershkovitz; Julio Wainstein; Ilana Harman-Boehm

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB24 COST EFFECTIVENESS ANALYSIS OF SWI

✍ E Suchankova; T Doležal; Z Pisarikova; K Rychna; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Cost-Effectiveness of Switching to Bipha

✍ Kyoung Hee Lee; Se Jin Seo; Jayne Smith-Palmer; James L. Palmer; Jeremy White; W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Effect of sulfonylureas on switching to

✍ C. Ebato; T. Shimizu; M. Arakawa; T. Mita; Y. Fujitani; H. Watada; R. Kawamori; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 314 KB

Addition of biphasic insulin aspart 30 t

✍ P. Raskin; G. Matfin; S. L. Schwartz; L. Chaykin; P.-L. Chu; R. Braceras; A. Wyn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Switching from biphasic human insulin 30

✍ Naggar, Nabil K. El; Soewondo, Pradana; Khamseh, Mohammad E.; Chen, Jian-Wen; Ha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 422 KB

PDB26 COMPARATIVE EVALUATION OF THE LONG

✍ D Cobden; L Nicklasson; P Raskin; A Garber; JA Ray; W Valentine; A Palmer; S Roz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB